Ignite Creation Date:
2024-05-06 @ 10:20 AM
Last Modification Date:
2024-10-26 @ 12:28 PM
Study NCT ID:
NCT03226678
Status:
COMPLETED
Last Update Posted:
2023-04-03
First Post:
2017-07-07
Brief Title:
Study to Assess the Safety Tolerability Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia wAIHA or Cold Agglutinin Disease CAD
Sponsor:
Apellis Pharmaceuticals Inc
Organization:
Apellis Pharmaceuticals Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Warm Autoimmune Hemolytic Anemia |
| Cold Agglutinin Disease |
Keywords: